Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25148003 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Gábor Méhes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of General Medicine, University of Debrecen, 4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Multiple Myeloma, Transplantation, Autologous, Leukemia, Erythroblastic, Acute. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The clinical impact of therapy-related acute leukemias is increasing with the extension of cancer-related survival; however, the origins remain largely unknown. Acute erythroleukemia (AEL), a rare unfavorable type of myeloid neoplasia, may also develop secondary to cytotoxic therapy. The disorder is featured by specific genetic alterations, most importantly multi-allelic mutations of the TP53 gene. While AEL might appear as a part of the therapy-related MDS/AML, spectrum information regarding the genetic complexity and progression is largely missing. We present two AEL cases arising after cytotoxic therapy and melphalan-based myeloablation/autologous peripheral stem cell transplantation due to multiple myeloma (MM). As stated, multiple pathogenic TP53 variants were present unrelated to preexisting MM, in parallel with uninvolved/wild-type hemopoiesis. Potential mechanisms of leukemic transformation are discussed, which include (1) preexisting preneoplastic hemopoietic stem cells (HSC) serving as the common origin for both MM and AEL, (2) the generation and intramedullary survival of p53-deficient post-chemotherapy HSCs, (3) reinoculation of mobilized autologous TP53 mutated HSCs, and (4) melphalan treatment-related late-onset myelodysplasia/leukemia with newly acquired TP53 mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Faculty of General Medicine, University of Debrecen, 4032 Debrecen, Hungary.
- Department of Laboratory Medicine, Faculty of General Medicine, University of Debrecen, 4032 Debrecen, Hungary.
- Department of Hematology, Institute of Internal Medicine, Faculty of General Medicine, University of Debrecen, 4032 Debrecen, Hungary.
ORCID-Profile: Anikó Ujfalusi, Zsuzsa Hevessy, Lajos Gergely, Judit Bedekovics
Zitieren
APA
Méhes, G., Mokánszki, A., Ujfalusi, A., Hevessy, Z., Miltényi, Z., Gergely, L., & Bedekovics, J. (2024). Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25148003
Vancouver
Méhes G, Mokánszki A, Ujfalusi A, Hevessy Z, Miltényi Z, Gergely L, et al. Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25148003
BibTeX
@article{Mhes2024,
author = {Méhes, Gábor and Mokánszki, Attila and Ujfalusi, Anikó and Hevessy, Zsuzsa and Miltényi, Zsófia and Gergely, Lajos and Bedekovics, Judit},
title = {Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25148003}
}
EUVIMED